FTC Workshop To Consider Generic Marketplace Changes, DTC Issues
Executive Summary
The Federal Trade Commission's upcoming healthcare workshop will consider changes in the generic marketplace since issuing a report in July
You may also be interested in...
GPO Study By GAO Will Examine Broad Range Of Products, HIGPA Says
An expanded report of hospital supply purchasing by the General Accounting Office may appear in early 2003, Health Industry Group Purchasing Association President Robert Betz reported Aug. 19
FTC Backs Single 30-Month Stay On Generic Rx Approvals In Patent Litigation
The Federal Trade Commission supports a limit of one 30-month stay of approval on generic drugs in patent litigation
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011